Abstract:Background Programmed necrosis/necroptosis is an emerging form of cell death that plays important roles in mammalian development and the immune system. The pro-necrotic kinases in the receptor interacting protein (RIP) family are crucial mediators of programmed necrosis. Recent advances in necrosis research have been greatly aided by the identification of chemical inhibitors that block programmed necrosis. Necrostatin-1 (Nec-1) and its derivatives were previously shown to target the pro-necrotic kinase RIP1/RIPK1. The protective effect conferred by Nec-1 and its derivatives in many experimental model systems was often attributed to the inhibition of RIP1 function. Methodology/Principal Findings We compared the effect of Nec-1 and siRNA-mediated silencing of RIP1 in the murine fibrosarcoma cell line L929. Treatment of L929 cells with the pan-caspase inhibitor zVAD-fmk or exogenous TNF induces necrosis. Strikingly, we found that siRNA-mediated silencing of RIP1 inhibited zVAD-fmk induced necrosis, but not TNF-induced necrosis. TNF-induced cell death in RIP1 knocked down L929 cells was inhibited by Nec-1, but not the caspase inhibitor zVAD-fmk. We found that PKA-C§ expression, but not Jnk or Erk activation, was moderately inhibited by Nec-1. Moreover, we found that Nec-1 inhibits proximal T cell receptor signaling independent of RIP1, leading to inhibition of T cell proliferation. Conclusions/Significance Our results reveal that besides RIP1, Nec-1 also targets other factors crucial for necrosis induction in L929 cells. In addition, high doses of Nec-1 inhibit other signal transduction pathways such as that for T cell receptor activation. These results highlight the importance to independently validate results obtained using Nec-1 with other approaches such as siRNA-mediated gene silencing. We propose that some of the previous published results obtained using Nec-1 should be re-evaluated in light of our findings.

A RNA interference screen identifies RIP3 as an essential inducer of TNF-induced programmed necrosis.

Inhibition of Receptor-Interacting Protein 3 Upregulation and Nuclear Translocation Involved in Necrostatin-1 Protection Against Hippocampal Neuronal Programmed Necrosis Induced by Ischemia/reperfusion Injury.

A Role for RIP1/RIP3-Dependent Programmed Necrosis in Innate Immune Responses Against Vaccinia Virus Infections

A Role for RIP1/RIP3-Dependent Programmed Necrosis in Innate Immune Responses Against Vaccinia Virus Infections (135.44)

Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation

RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF

[Research Progress on Receptor Interacting Proteins in Inflammation].

Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation

RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis

RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity.

RIP3: a Molecular Switch for Necrosis and Inflammation.

TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members

Positive and Negative Phosphorylation Regulates RIP1- and RIP3-induced Programmed Necrosis

Regulation of Innate Immune Responses by Receptor Interacting Protein Kinases (172.43)

Necrosis-dependent and independent signaling of the RIP kinases in inflammation.

Mechanisms of RIPK3‐induced inflammation

RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome

Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3–mediated pathway

A Study of the Signaling Pathway and Effector Mechanisms of TNF-induced Programmed Necrosis (84.13)